2Shorrn,Seiff St Kopelmanj.The use of botulium toxin in blepharo-spasm[J].Am J Ophthalmol,1985,99(5):542.
3Jankovic J,Kenneths,Schwatz PA.Longittudinal experience with botulium toxin injections for treatment of blepharospasm and cervical dystonia[J].Neruology,1993,43:834.
4Olney RK,Aminoff MJ,Lowenstein DH.Neuromuscular effects disrant from the site of botulinum neurotoxin injection[J].Neeurology,1997,38:1780.
5Jankovie J, Leder S, Warner D, et al. Cervical dystonia: clin findings associated movement disorders. Neurology, 1991,41 (4) :1088-1091.
6Greene P, Kang U, Fahn S, et al. Double-blind placebo-con- trolled trial of Botulinum toxin :niections for the treatment of spasmodic torticollis. Neurology, 1990,40 : 1213.
7Dauer WT, Burke RE, Greene P,et al. Current concepts on the clinical features, aetiology and management of idiopathic cervical dystonia. Brain, 1998,121 : 547-560.
8Brahs JW,de Boer IP, Aramideh M, et al. Botulinum toxin in cervical dystonia: low dosage with electromyographic guid- ance. J Neurol,1995,2:2(8) :529-534.
9Bhatia KP, Munchau A, Thompson PD, et al. Generalised muscular weakness after botulinum toxin injections for dysto- nia: areport of three eases. J Neurol Neurosurg Psychiatry, 1999,67(1) :90-93.
10Schantz EJ, Johnson EA. Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev, 1992,56(1) :80-99.
